177 related articles for article (PubMed ID: 35919227)
1. Three-week hypofractionated radiotherapy in early glottic cancer-a single institution retrospective study.
Sudha AS; Kumar RR; Anjanappa M; Kainickal CT; Mathew A; Kunnambath R
Ecancermedicalscience; 2022; 16():1381. PubMed ID: 35919227
[TBL] [Abstract][Full Text] [Related]
2. Hypofractionated radiotherapy for T1N0M0 glottic cancer: retrospective analysis of two different cohorts of dose-fractionation schedules from a single institution.
Laskar SG; Baijal G; Murthy V; Chilukuri S; Budrukkar A; Gupta T; Agarwal JP
Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e180-6. PubMed ID: 22862908
[TBL] [Abstract][Full Text] [Related]
3. Results of radiotherapy for T2N0 glottic carcinoma: does the "2" stand for twice-daily treatment?
Garden AS; Forster K; Wong PF; Morrison WH; Schechter NR; Ang KK
Int J Radiat Oncol Biol Phys; 2003 Feb; 55(2):322-8. PubMed ID: 12527044
[TBL] [Abstract][Full Text] [Related]
4. Hypofractionated radiotherapy and surgery compared to standard radiotherapy in early glottic cancer.
Kim KN; Dyer MA; Qureshi MM; Shah NK; Grillone GA; Faden DL; Jalisi SM; Truong MT
Am J Otolaryngol; 2020; 41(5):102544. PubMed ID: 32505989
[TBL] [Abstract][Full Text] [Related]
5. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.
Le QT; Fu KK; Kroll S; Ryu JK; Quivey JM; Meyler TS; Krieg RM; Phillips TL
Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):115-26. PubMed ID: 9300746
[TBL] [Abstract][Full Text] [Related]
6. Study Protocol: Prospective Study of Concurrent Chemoradiotherapy with S-1 and Hypofractionated Radiotherapy for Outpatients with Early Glottic Squamous Cell Carcinomas.
Kimura K; Itoh Y; Okada T; Kubota S; Kawamura M; Nakahara R; Oie Y; Kozai Y; Takase Y; Tsuzuki H; Nishio N; Hiramatsu M; Fujimoto Y; Mizutani T; Hirakawa A; Naganawa S
Asian Pac J Cancer Prev; 2018 May; 19(5):1195-1199. PubMed ID: 29801401
[TBL] [Abstract][Full Text] [Related]
7. The impact of treatment time and smoking on local control and complications in T1 glottic cancer.
van der Voet JC; Keus RB; Hart AA; Hilgers FJ; Bartelink H
Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):247-55. PubMed ID: 9788401
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy of early-stage glottic cancer: analysis of factors affecting prognosis.
Chen MF; Chang JT; Tsang NM; Liao CT; Chen WC
Ann Otol Rhinol Laryngol; 2003 Oct; 112(10):904-11. PubMed ID: 14587984
[TBL] [Abstract][Full Text] [Related]
9. Hypofractionated radiotherapy versus conventional radiotherapy in early glottic cancer T1-2N0M0: A randomized study.
Kachhwaha A; Jakhar SL; Syiem T; Sharma N; Kumar HS; Sharma A
J Cancer Res Ther; 2021; 17(6):1499-1502. PubMed ID: 34916384
[TBL] [Abstract][Full Text] [Related]
10. Definitive hypofractionated radiotherapy for early glottic carcinoma: experience of 55Gy in 20 fractions.
Ermiş E; Teo M; Dyker KE; Fosker C; Sen M; Prestwich RJ
Radiat Oncol; 2015 Sep; 10():203. PubMed ID: 26395876
[TBL] [Abstract][Full Text] [Related]
11. Hypofractionation vs. conventional radiotherapy fractionation in the conservative treatment of T1 glottic cancer: a prospective cohort study.
Salas-Salas BG; Domínguez-Nuez DJ; Cabrera R; Ferrera-Alayón L; Lloret M; Lara PC
Clin Transl Oncol; 2020 Jan; 22(1):151-157. PubMed ID: 31152306
[TBL] [Abstract][Full Text] [Related]
12. Hypofractionated radiotherapy for early glottic cancer: a retrospective interim analysis of a single institution.
Lee JW; Lee JE; Park J; Sohn JH; Ahn D
Radiat Oncol J; 2019 Jun; 37(2):82-90. PubMed ID: 31266289
[TBL] [Abstract][Full Text] [Related]
13. The outcome of early-stage glottic carcinoma patients treated with radiotherapy: Egyptian National Cancer Institute (NCI-Egypt) experience.
Mohamed AE; Hassouna AH; Mosalum HS; Alnagmy AK; Ashour MG
Rep Pract Oncol Radiother; 2023; 28(4):496-505. PubMed ID: 37795222
[TBL] [Abstract][Full Text] [Related]
14. 3D conformal hypofractionated radical radiotherapy in early glottic cancer.
Amado AC; Bujor L; Monteiro Grillo I
Rep Pract Oncol Radiother; 2013 May; 18(5):261-4. PubMed ID: 24416562
[TBL] [Abstract][Full Text] [Related]
15. [Early stages of laryngeal cancer (I-II stage) and therapeutic options: case report and review of literature].
Margarino G; Schenone G; Scala M; Mereu P; Comandini D; Corvo R; Scolaro T; Badellino F
Acta Otorhinolaryngol Ital; 1996 Feb; 16(1):40-6. PubMed ID: 8984839
[TBL] [Abstract][Full Text] [Related]
16. [Radiotherapy for patients with early-stage glottic squamous cell carcinoma of the larynx: Interest of hypofractionation?].
Tonneau M; Matta R; Lals S; Mirabel X; Crop F; Lacornerie T; Pasquier D; Escande A; Liem X
Cancer Radiother; 2021 Dec; 25(8):801-810. PubMed ID: 33931299
[TBL] [Abstract][Full Text] [Related]
17. Conventional fractionation should not be the standard of care for T2 glottic cancer.
Dixon LM; Douglas CM; Shaukat SI; Garcez K; Lee LW; Sykes AJ; Thomson D; Slevin NJ
Radiat Oncol; 2017 Nov; 12(1):178. PubMed ID: 29137654
[TBL] [Abstract][Full Text] [Related]
18. Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.
Zouhair A; Azria D; Coucke P; Matzinger O; Bron L; Moeckli R; Do HP; Mirimanoff RO; Ozsahin M
Strahlenther Onkol; 2004 Feb; 180(2):84-90. PubMed ID: 14762660
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients.
Franchin G; Minatel E; Gobitti C; Talamini R; Vaccher E; Sartor G; Politi D; Trovò MG; Barzan L
Cancer; 2003 Aug; 98(4):765-72. PubMed ID: 12910521
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of p53 protein does not predict local-regional control or survival in patients with early-stage squamous cell carcinoma of the glottic larynx treated with radiotherapy.
Pai HH; Rochon L; Clark B; Black M; Shenouda G
Int J Radiat Oncol Biol Phys; 1998 Apr; 41(1):37-42. PubMed ID: 9588915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]